|
DDX5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.277210E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.183100E-03 |
| Normal-vs-Stage2 |
1.879800E-01 |
| Normal-vs-Stage3 |
6.520800E-01 |
| Normal-vs-Stage4 |
6.024600E-01 |
| Stage1-vs-Stage2 |
8.735800E-01 |
| Stage1-vs-Stage3 |
3.200000E-03 |
| Stage1-vs-Stage4 |
1.401900E-02 |
| Stage2-vs-Stage3 |
1.178190E-01 |
| Stage2-vs-Stage4 |
1.101550E-01 |
| Stage3-vs-Stage4 |
8.780000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.531600E-01 |
| Normal-vs-AfricanAmerican |
1.119530E-02 |
| Normal-vs-Asian |
1.039760E-01 |
| Caucasian-vs-AfricanAmerican |
2.679600E-02 |
| Caucasian-vs-Asian |
3.825400E-01 |
| AfricanAmerican-vs-Asian |
8.599800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.807200E-01 |
| Normal-vs-Female |
1.183510E-04 |
| Male-vs-Female |
1.13540000001855E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.302000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.279700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.494000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.944200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.836020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.599400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.551800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.453000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.489800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.475200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.575640E-02 |
| Normal-vs-Grade 2 |
1.377990E-03 |
| Normal-vs-Grade 3 |
9.032000E-01 |
| Normal-vs-Grade 4 |
7.208200E-02 |
| Grade 1-vs-Grade 2 |
1.059870E-02 |
| Grade 1-vs-Grade 3 |
1.464190E-02 |
| Grade 1-vs-Grade 4 |
5.278900E-03 |
| Grade 2-vs-Grade 3 |
5.243100E-04 |
| Grade 2-vs-Grade 4 |
4.41170000000657E-05 |
| Grade 3-vs-Grade 4 |
9.134500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.37690000000668E-05 |
| Normal-vs-ccB subtype |
1.055770E-01 |
| ccA subtype-vs-ccB subtype |
3.36850003446187E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.253970E-01 |
| Normal-vs-N1 |
3.920300E-02 |
| N0-vs-N1 |
4.528200E-02 |
|
|
